TDZD8
An experimental compound which was being developed for the potential treatment of Alzheimer's disease. It has a role as an EC 2.7.11.26 (tau-protein kinase) inhibitor, an apoptosis inducer, an antineoplastic agent, a neuroprotective agent and an anti-inflammatory agent.
General
Type : Not AlphaBeta Hydrolase target, GSK-3 kinase inhibitor, Thiadiazol, Sulfur Compound
Chemical_Nomenclature : 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
Canonical SMILES : CN1C(=O)N(C(=O)S1)CC2=CC=CC=C2
InChI : InChI=1S\/C10H10N2O2S\/c1-11-9(13)12(10(14)15-11)7-8-5-3-2-4-6-8\/h2-6H,7H2,1H3
InChIKey : JDSJDASOXWCHPN-UHFFFAOYSA-N
Other name(s) : U3W || TDZD-8 || GSK-3beta Inhibitor I || TDZD 8 || SCHEMBL139834 || ZINC27361 || CHEBI:147411
MW : 222.27
Formula : C10H10N2O2S
CAS_number : 327036-89-5
PubChem : 4124851
UniChem : JDSJDASOXWCHPN-UHFFFAOYSA-N
Target
Families : TDZD8 ligand of proteins in family
Pectinacetylesterase-Notum
Structure :
7BMD
Protein :
human-NOTUM
References
No reference